Evaluation of Apelin-13 and Apelin-36 in Women With Recurrent Pregnancy Loss

NCT05205044 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2023-02-14

No results posted yet for this study

Summary

Lower Apelin levels are associated with hypertensive disorders with pregnancy, yet no studies investigated its levels in recurrent pregnancy loss

Conditions

  • Recurrent Pregnancy Loss

Interventions

DIAGNOSTIC_TEST

Apelin-13, Apelin-36

Serum levels of Apelin-13 and Apelin-36

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-23
Primary Completion
2023-01-30
Completion
2023-01-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05205044 on ClinicalTrials.gov